Reaction

Viral Haemorrhagic Cystitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 697 reports · 47 co-occurring drugs

As of the last recalculation, Viral Haemorrhagic Cystitis appears in 697 FAERS reports alongside 47 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 567.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Thiotepa	144	567.3	576.0
Busulfan	198	524.5	531.2
Fludarabine Phosphate	291	378.7	381.5
Ganciclovir	50	157.1	157.9
Ganciclovir Sodium	50	151.9	152.6
Melphalan	66	95.6	95.9
Anti-Thymocyte Globulin (Rabbit)	24	92.0	92.2
Melphalan Hydrochloride	69	91.1	91.4
Cyclophosphamide Injection, Solution	284	80.2	80.3
Cyclophosphamide	284	80.2	80.3
Cyclophosphamide For Injection	284	80.2	80.3
Alemtuzumab	47	77.7	77.9
Cyclosporine	205	77.5	77.7
Tacrolimus Ointment 0.1%	221	77.1	77.3
Tacrolimus Extended-Release Capsules	221	76.9	77.1
Mycophenolate Mofetil	233	76.5	76.6
Mycophenolate Mofetil Hydrochloride	233	76.3	76.4
Basiliximab	28	74.0	74.2
Tacrolimus	250	73.8	73.9
Sirolimus	26	59.8	59.9
Posaconazole Delayed-Release	20	56.0	56.1
Valganciclovir Hydrochloride Powder,	19	47.8	47.9
Micafungin Sodium	13	46.6	46.7
Posaconazole	24	45.6	45.7
Cytarabine	71	39.2	39.2
Valganciclovir	23	37.6	37.7
Valganciclovir Hydrochloride	23	37.6	37.7
Voriconazole	36	37.3	37.3
Filgrastim	44	37.2	37.3
Voriconazole Injection	25	35.6	35.7
Imatinib	20	34.8	34.9
Mesna Injection	9	32.9	33.0
Mesna	9	32.3	32.4
Etoposide	69	31.0	31.0
Vincristine Sulfate	28	29.7	29.7
Amphotericin B	11	26.6	26.6
Mycophenilic Acid	16	23.6	23.6
Meropenem	23	22.1	22.1
Bendamustine Hydrochloride	8	20.2	20.2
Ifosfamide	14	19.8	19.8
Ruxolitinib	41	18.1	18.1
Polatuzumab Vedotin	5	15.4	15.4
Doxorubicin	41	14.5	14.5
Blinatumomab	5	14.4	14.4
Doxorubicin Hydrochloride	15	14.0	14.0
Azacitidine For	8	13.3	13.3
Azacitidine	10	10.2	10.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.